Does Shared Decision-Making Improve Long-Term Lung Cancer Screening Adherence?

Lung cancer screening with low-dose CT (LDCT) has well-established mortality benefits, yet real-world uptake and adherence remain major challenges. Health systems have implemented specific requirements—such as shared decision-making (SDM) visits—to improve patient engagement and sustain annual screening. But does this approach actually influence whether patients continue screening over time? This question sits at the intersection of policy, patient behavior, and clinical outcomes.

Which of the following statements best reflects the impact of shared decision-making (SDM) visits in lung cancer screening (LCS) programs for Medicare beneficiaries?

©2026 HMP Global. All Rights Reserved.
Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of Consultant360 or HMP Global, their employees, and affiliates.